• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipMarco Rubio

Marco Rubio calls out high drug prices

By
Ben Geier
Ben Geier
Down Arrow Button Icon
By
Ben Geier
Ben Geier
Down Arrow Button Icon
October 19, 2015, 5:23 PM ET
Marco Rubio
Republican presidential candidate Sen. Marco Rubio, R-Fla., speaks at 1871, an entrepreneurial hub for digital startups Tuesday, July 7, 2015, in Chicago. Rubio outlined a plan to lower corporate tax rates, loosen Internet regulation and broaden college accreditation, in his first major domestic policy speech as a presidential candidate. (AP Photo/Christian K. Lee)Photograph by Christian K. Lee — AP

There’s been a lot of talk lately about how drug companies are profiteering on people’s illnesses and how the government needs to rein that in — as one would expect, most of that talk as been from Democrats. At least one Republican, though wants to get in on it.

Marco Rubio added his voice to the chorus of politicians bringing drug companies to task for charging insanely high prices.

“These companies decide, ‘We can get away with charging it, and so we do,'” the Florida Senator said last week, according to Bloomberg Politics.

Drug companies were in the spotlight during last week’s Democratic debate, when multiple candidates listed drug companies as the groups they were most proud to have as enemies. “Big Pharma” has traditionally been a solidly Republican donor and lobbying base.

Rubio’s campaign did walk back the statement slightly, noting that the candidate was only referring to some companies, but this does add a new wrinkle to the ongoing election process.

In an election that has focused on “outsider” candidates like Donald Trump, Carly Fiorina, and Ben Carson, Rubio is currently the highest-polling Republican who has actual political experience. If things end up going sideways for the three “outsiders,” as many still expect them to, Rubio would be the candidate best-positioned to swoop in and commandeer the race — a position he was able to move into following the well-documented struggles of fellow Floridian Jeb Bush.

Calling out the drug companies, though, would do well to endear Rubio to voters in a cycle increasingly driven by populist sentiments. If nothing else, it positions him to take on Hillary Clinton or Bernie Sanders on the issue in a general election if he does capture the nomination.

About the Author
By Ben Geier
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.